To establish the cytotoxic antitumor efficacy of NGF, PG-1, and LL-37 combinations with chemotherapeutic agents on C6 glioma cell culture, we compared their IC50 with the IC50 of chemotherapy using an MTT assay and trypan blue staining (Table 3 and Table 4). This evidence concerns the gene NGF and central nervous system cancer.